Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 50 of 129

1.

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA; ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA); CEPAC International investigators.

PLoS Med. 2009 Oct;6(10):e1000173. Epub 2009 Oct 27.PMID: 19859538 [PubMed - in process]Related articlesFree article

2.

Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RD, Paltiel AD, Freedberg KA.

Clin Infect Dis. 2009 Nov 15;49(10):1570-8.PMID: 19845472 [PubMed - in process]Related articles

3.

HIV/AIDS, undernutrition, and food insecurity.

Ivers LC, Cullen KA, Freedberg KA, Block S, Coates J, Webb P.

Clin Infect Dis. 2009 Oct 1;49(7):1096-102. Review.PMID: 19725790 [PubMed - indexed for MEDLINE]Related articles

4.

When to start antiretroviral therapy in resource-limited settings.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators.

Ann Intern Med. 2009 Aug 4;151(3):157-66. Epub 2009 Jul 20.PMID: 19620143 [PubMed - indexed for MEDLINE]Related articles

5.

HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies.

April MD, Walensky RP, Chang Y, Pitt J, Freedberg KA, Losina E, Paltiel AD, Wood R.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):310-6.PMID: 19582895 [PubMed - indexed for MEDLINE]Related articles

6.

HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme.

Orrell C, Walensky RP, Losina E, Pitt J, Freedberg KA, Wood R.

Antivir Ther. 2009;14(4):523-31.PMID: 19578237 [PubMed - indexed for MEDLINE]Related articles

7.

Improving outcomes in state AIDS drug assistance programs.

Linas BP, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KA.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):513-21.PMID: 19561518 [PubMed - indexed for MEDLINE]Related articles

8.

Loss to care and death before antiretroviral therapy in Durban, South Africa.

Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, Lu Z, Losina E, Walensky RP, Freedberg KA.

J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):135-9.PMID: 19504725 [PubMed - indexed for MEDLINE]Related articlesFree article

9.

Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents.

Ciaranello AL, Walensky RP, Sax PE, Chang Y, Freedberg KA, Weissman JS.

HIV Clin Trials. 2009 Jan-Feb;10(1):13-24. Review.PMID: 19362992 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.

Paltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, Seage GR 3rd, Sloan CE, Sax PE, Walensky RP.

Clin Infect Dis. 2009 Mar 15;48(6):806-15.PMID: 19193111 [PubMed - indexed for MEDLINE]Related articles

11.

Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.

Ciaranello AL, Seage GR 3rd, Freedberg KA, Weinstein MC, Lockman S, Walensky RP.

AIDS. 2008 Nov 12;22(17):2359-69.PMID: 18981776 [PubMed - indexed for MEDLINE]Related articles

12.

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

Schackman BR, Scott CA, Walensky RP, Losina E, Freedberg KA, Sax PE.

AIDS. 2008 Oct 1;22(15):2025-33.PMID: 18784465 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infection.

Bassett IV, Giddy J, Wang B, Lu Z, Losina E, Freedberg KA, Walensky RP.

HIV Med. 2008 Nov;9(10):863-7. Epub 2008 Aug 27.PMID: 18754802 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

Monitoring of antiretroviral therapy in low-resource settings.

Walensky RP, Freedberg KA, Weinstein MC.

Lancet. 2008 Jul 26;372(9635):288; author reply 289. No abstract available. PMID: 18657699 [PubMed - indexed for MEDLINE]Related articles

15.

Late diagnosis of HIV infection at two academic medical centers: 1994-2004.

Jean-Jacques M, Walensky RP, Aaronson WH, Chang Y, Freedberg KA.

AIDS Care. 2008 Sep;20(8):977-83.PMID: 18608072 [PubMed - indexed for MEDLINE]Related articles

16.

Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.

Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA; CEPAC-International Investigators.

J Infect Dis. 2008 May 1;197(9):1324-32.PMID: 18422445 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa.

Ojikutu BO, Zheng H, Walensky RP, Lu Z, Losina E, Giddy J, Freedberg KA.

S Afr Med J. 2008 Mar;98(3):204-8.PMID: 18350223 [PubMed - indexed for MEDLINE]Related articlesFree article

18.

Cost-effectiveness of HIV testing and treatment in the United States.

Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD.

Clin Infect Dis. 2007 Dec 15;45 Suppl 4:S248-54. Review.PMID: 18190295 [PubMed - indexed for MEDLINE]Related articlesFree article

19.

Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients.

Valerio L, Yazdanpanah Y, Poizot-Martin I, Rosenthal E, Marimoutou C, Gastaut JA, Tran A, Dellamonica P, Freedberg KA, Pradier C.

J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):50-5.PMID: 18156991 [PubMed - indexed for MEDLINE]Related articlesFree article

20.

The cost-effectiveness of antiretroviral therapy for treating HIV disease in the Caribbean.

Wolf LL, Ricketts P, Freedberg KA, Williams-Roberts H, Hirschhorn LR, Allen-Ferdinand K, Rodriguez WR, Divi N, Wong MT, Losina E.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):463-71.PMID: 18077836 [PubMed - indexed for MEDLINE]Related articlesFree article

22.

Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.

Freedberg KA, Kumarasamy N, Losina E, Cecelia AJ, Scott CA, Divi N, Flanigan TP, Lu Z, Weinstein MC, Wang B, Ganesh AK, Bender MA, Mayer KH, Walensky RP.

AIDS. 2007 Jul;21 Suppl 4:S117-28.PMID: 17620747 [PubMed - indexed for MEDLINE]Related articlesFree article

23.

Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.

Schackman BR, Scott CA, Sax PE, Losina E, Wilkin TJ, McKinnon JE, Swindells S, Weinstein MC, Freedberg KA.

Clin Infect Dis. 2007 Oct 15;45(8):1062-70. Epub 2007 Sep 4.PMID: 17879926 [PubMed - indexed for MEDLINE]Related articlesFree article

24.

Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling.

Deuffic-Burban S, Losina E, Wang B, Gabillard D, Messou E, Divi N, Freedberg KA, Anglaret X, Yazdanpanah Y.

Eur J Epidemiol. 2007;22(10):737-44. Epub 2007 Sep 8.PMID: 17828437 [PubMed - indexed for MEDLINE]Related articlesFree article

25.

The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.

Yazdanpanah Y, Vray M, Meynard J, Losina E, Weinstein MC, Morand-Joubert L, Goldie SJ, Hsu HE, Walensky RP, Dalban C, Sax PE, Girard PM, Freedberg KA.

HIV Med. 2007 Oct;8(7):439-50.PMID: 17760736 [PubMed - indexed for MEDLINE]Related articles

26.

HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993--2005.

Losina E, Figueroa P, Duncan J, Divi N, Wolf LL, Hirschhorn LR, Robertson M, Harvey K, Whorms S, Freedberg KA, Gebre Y.

Int J Infect Dis. 2008 Mar;12(2):132-8. Epub 2007 Aug 13.PMID: 17706448 [PubMed - indexed for MEDLINE]Related articlesFree article

27.

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

Losina E, Yazdanpanah Y, Deuffic-Burban S, Wang B, Wolf LL, Messou E, Gabillard D, Seyler C, Freedberg KA, Anglaret X.

Antivir Ther. 2007;12(4):543-51.PMID: 17668563 [PubMed - indexed for MEDLINE]Related articles

28.

Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department.

Bassett IV, Giddy J, Nkera J, Wang B, Losina E, Lu Z, Freedberg KA, Walensky RP.

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):181-6.PMID: 17667332 [PubMed - indexed for MEDLINE]Related articlesFree article

29.

HIV drug resistance surveillance for prioritizing treatment in resource-limited settings.

Walensky RP, Weinstein MC, Yazdanpanah Y, Losina E, Mercincavage LM, Touré S, Divi N, Anglaret X, Goldie SJ, Freedberg KA; CEPAC International Investigators.

AIDS. 2007 May 11;21(8):973-82.PMID: 17457091 [PubMed - indexed for MEDLINE]Related articlesFree article

30.

Late presentation for HIV care in central Haiti: factors limiting access to care.

Louis C, Ivers LC, Smith Fawzi MC, Freedberg KA, Castro A.

AIDS Care. 2007 Apr;19(4):487-91.PMID: 17453588 [PubMed - indexed for MEDLINE]Related articles

31.

The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men.

McCormick AW, Walensky RP, Lipsitch M, Losina E, Hsu H, Weinstein MC, Paltiel AD, Freedberg KA, Seage GR 3rd.

Clin Infect Dis. 2007 Apr 15;44(8):1115-22. Epub 2007 Mar 9.PMID: 17366461 [PubMed - indexed for MEDLINE]Related articlesFree article

32.

Response to "CD4 cell count natural history and informative censoring in sub-Saharan Africa".

Holmes CB, Wood R, Maartens G, Freedberg KA, Losina E.

J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):491. No abstract available. PMID: 17353721 [PubMed - indexed for MEDLINE]Related articles

33.

Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.

Campos NG, Salomon JA, Servoss JC, Nunes DP, Samet JH, Freedberg KA, Goldie SJ.

Am J Med. 2007 Mar;120(3):272-9.PMID: 17349451 [PubMed - indexed for MEDLINE]Related articlesFree article

34.

Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment.

Schackman BR, Freedberg KA, Goldie SJ, Weinstein MC, Swartz K.

Health Care Financ Rev. 2005 Summer;26(4):67-80.PMID: 17288069 [PubMed - indexed for MEDLINE]Related articles

35.

Visual screening for malignant melanoma: a cost-effectiveness analysis.

Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA.

Arch Dermatol. 2007 Jan;143(1):21-8.PMID: 17224538 [PubMed - indexed for MEDLINE]Related articlesFree article

36.

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, Freedberg KA.

Ann Intern Med. 2006 Dec 5;145(11):797-806.PMID: 17146064 [PubMed - indexed for MEDLINE]Related articlesFree article

37.

Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients.

Freedberg KA, Hirschhorn LR, Schackman BR, Wolf LL, Martin LA, Weinstein MC, Goldin S, Paltiel AD, Katz C, Goldie SJ, Losina E.

J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S113-8.PMID: 17133193 [PubMed - indexed for MEDLINE]Related articles

38.

Predictors of antiretroviral treatment failure in an urban HIV clinic.

Robbins GK, Daniels B, Zheng H, Chueh H, Meigs JB, Freedberg KA.

J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):30-7.PMID: 17106280 [PubMed - indexed for MEDLINE]Related articlesFree article

39.

The lifetime cost of current human immunodeficiency virus care in the United States.

Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR 3rd, Moore RD, Freedberg KA.

Med Care. 2006 Nov;44(11):990-7. Review.PMID: 17063130 [PubMed - indexed for MEDLINE]Related articles

40.

Optimizing resource allocation in United States AIDS drug assistance programs.

Linas BP, Zheng H, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KA.

Clin Infect Dis. 2006 Nov 15;43(10):1357-64. Epub 2006 Oct 17.PMID: 17051505 [PubMed - indexed for MEDLINE]Related articles

41.

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA.

N Engl J Med. 2006 Sep 14;355(11):1141-53.PMID: 16971720 [PubMed - indexed for MEDLINE]Related articlesFree article

42.

Implementing a routine, voluntary HIV testing program in a Massachusetts county prison.

Liddicoat RV, Zheng H, Internicola J, Werner BG, Kazianis A, Golan Y, Rubinstein EP, Freedberg KA, Walensky RP.

J Urban Health. 2006 Nov;83(6):1127-31.PMID: 16897416 [PubMed - indexed for MEDLINE]Related articles

43.

Diagnostic tests in HIV management: a review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries.

Kimmel AD, Losina E, Freedberg KA, Goldie SJ.

Bull World Health Organ. 2006 Jul;84(7):581-8. Review.PMID: 16878233 [PubMed - indexed for MEDLINE]Related articlesFree article

44.

Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire.

Losina E, Anglaret X, Yazdanpanah Y, Wang B, Toure S, Seage GR 3rd, N'Dri-Yoman T, Walensky RP, Dakoury-Dogbo N, Goldie SJ, Messou E, Weinstein MC, Deuffic-Burban S, Salamon R, Freedberg KA.

S Afr Med J. 2006 Jun;96(6):526-9.PMID: 16841136 [PubMed - indexed for MEDLINE]Related articlesFree article

45.

CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment.

Holmes CB, Wood R, Badri M, Zilber S, Wang B, Maartens G, Zheng H, Lu Z, Freedberg KA, Losina E.

J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):464-9.PMID: 16810113 [PubMed - indexed for MEDLINE]Related articles

46.

Therapeutic drug monitoring in HIV treatment: a literature review.

Wertheimer BZ, Freedberg KA, Walensky RP, Yazdanapah Y, Losina E.

HIV Clin Trials. 2006 Mar-Apr;7(2):59-69. Review.PMID: 16798621 [PubMed - indexed for MEDLINE]Related articles

47.

The survival benefits of AIDS treatment in the United States.

Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA.

J Infect Dis. 2006 Jul 1;194(1):11-9. Epub 2006 Jun 1.PMID: 16741877 [PubMed - indexed for MEDLINE]Related articles

48.

Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost.

Holmes CB, Zheng H, Martinson NA, Freedberg KA, Walensky RP.

Clin Infect Dis. 2006 Jun 15;42(12):1772-80. Epub 2006 May 12.PMID: 16705586 [PubMed - indexed for MEDLINE]Related articles

49.

Assessing the impact of federal HIV prevention spending on HIV testing and awareness.

Linas BP, Zheng H, Losina E, Walensky RP, Freedberg KA.

Am J Public Health. 2006 Jun;96(6):1038-43. Epub 2006 May 2.PMID: 16670217 [PubMed - indexed for MEDLINE]Related articlesFree article

50.

Variations in self-rated health among patients with HIV infection.

Mrus JM, Schackman BR, Wu AW, Freedberg KA, Tsevat J, Yi MS, Zackin R.

Qual Life Res. 2006 Apr;15(3):503-14.PMID: 16547789 [PubMed - indexed for MEDLINE]Related articles

Supplemental Content

Find related data

Search details

» See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

» See more...